Sujan Shresta

Title: Sujan Shresta: Innovator in Flavivirus Research

Introduction

Sujan Shresta is a prominent inventor based in San Diego, California. He has made significant contributions to the field of immunology, particularly in the study of flavivirus peptides and their applications in therapeutic and preventative measures.

Latest Patents

Sujan Shresta holds two notable patents. The first patent is titled "Flavivirus peptide sequences, epitopes, and methods and uses thereof." This invention relates to the composition of matter, processes, and uses of flavivirus peptides and epitopes. It aims to provide therapeutic or preventative vaccination against flavivirus infections, such as Zika and Dengue viruses. The second patent is "Dengue virus (DV) polypeptide sequences, T cell epitopes and methods and uses thereof." This patent includes DV peptides, nucleotide sequences, and compositions that can elicit and enhance immune responses against Dengue virus infections.

Career Highlights

Sujan Shresta is affiliated with the La Jolla Institute for Allergy and Immunology, where he conducts groundbreaking research in immunology. His work focuses on developing innovative solutions to combat flavivirus-related diseases.

Collaborations

Sujan collaborates with esteemed colleagues, including Lauren Yauch and Alessandro D Sette, to advance research in the field of immunology and vaccine development.

Conclusion

Sujan Shresta's contributions to flavivirus research and his innovative patents highlight his role as a key figure in the field of immunology. His work continues to pave the way for advancements in therapeutic and preventative measures against viral infections.